Inix Technologies Holdings Bhd clarified a news report titled "INIX Technologies' application to supply Covid-19 vaccines yet to be received by NPRA" by The Edge Media Group. The Group, via its subsidiary, has submitted its application, for the registration with the Malaysian National Pharmaceutical Regulatory Agency (NPRA) under the Ministry of Health in relation to its agreement to source vaccines for COVID-19, from China. Its suppliers for the COVID-19 vaccines are Sinovac Biotech Co Ltd, CanSino Biologic Inc. and Sinopharm China /National Biotech Group Co Ltd. The application was made by INIX and received by NPRA on 11 January 2021. The authority has since requested additional information in relation to the application. Currently, the Group is in the midst of preparing the additional information requested by NPRA.